AAAAAA

   
Results: 1-8 |
Results: 8
Biocompatibility and performance of the wallstent and several covered stents in a sheep iliac artery model (vol 12, pg 351, 2001)
Authors: Cejna, M Virmani, R Jones, R Bergmeister, H Losert, U Xu, ZY Yang, P Schoder, M Lammer, J
Citation: M. Cejna et al., Biocompatibility and performance of the wallstent and several covered stents in a sheep iliac artery model (vol 12, pg 351, 2001), J VAS INT R, 12(5), 2001, pp. 587-587
Biocompatibility and performance of the wallstent and several covered stents in a sheep iliac artery model
Authors: Cejna, M Virmani, R Jones, R Bergmeister, H Losert, U Xu, ZY Yang, P Schoder, M Lammer, J
Citation: M. Cejna et al., Biocompatibility and performance of the wallstent and several covered stents in a sheep iliac artery model, J VAS INT R, 12(3), 2001, pp. 351-358
Morphologic changes in heterotopically transplanted rat heart isografts
Authors: Nourani, F Laufer, G Hollensteiner, H Windberger, U Macfelda, K Traxler, H Schuster, MD McCue, JD Solomon, D Schlechta, B Losert, U Wolner, E Kocher, AA
Citation: F. Nourani et al., Morphologic changes in heterotopically transplanted rat heart isografts, TRANSPLAN P, 33(5), 2001, pp. 2755-2756
Neovascularisation of the testes by experimental omentotesticulopexy
Authors: Lobl, M Frigo, E Beer, F Depine, C Losert, U Rokitansky, AM
Citation: M. Lobl et al., Neovascularisation of the testes by experimental omentotesticulopexy, PEDIAT SURG, 16(8), 2000, pp. 576-579
Epinephrine application via an endotracheal airway and via the Combitube in esophageal position
Authors: Kofler, J Sterz, F Hofbauer, R Rodler, S Schuster, E Winkler, M Schwendenwein, I Losert, U Bieglmayer, C Benumof, JL Frass, M
Citation: J. Kofler et al., Epinephrine application via an endotracheal airway and via the Combitube in esophageal position, CRIT CARE M, 28(5), 2000, pp. 1445-1449
Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced-stage pancreatic carcinoma: a phase I/II study
Authors: Lohr, M Bago, ZT Bergmeister, H Ceijna, M Freund, R Gelbmann, W Gunzburg, WH Jesnowski, R Hain, J Hauenstein, K Henninger, W Hoffmeyer, A Karle, P Kroger, JC Kundt, G Liebe, S Losert, U Muller, P Probst, A Puschel, K Renner, M Renz, R Saller, R Salmons, B Schuh, M Schwendenwein, I von Rombs, K Wagner, T Walter, I
Citation: M. Lohr et al., Cell therapy using microencapsulated 293 cells transfected with a gene construct expressing CYP2B1, an ifosfamide converting enzyme, instilled intra-arterially in patients with advanced-stage pancreatic carcinoma: a phase I/II study, J MOL MED-J, 77(4), 1999, pp. 393-398
Microspheres based detoxification system: in vitro study and mathematical estimation of filter performance
Authors: Willinger, M Schima, H Schmidt, C Huber, L Vogt, G Falkenhagen, D Losert, U
Citation: M. Willinger et al., Microspheres based detoxification system: in vitro study and mathematical estimation of filter performance, INT J ARTIF, 22(8), 1999, pp. 573-582
Modified technique of delivering solutions to rat coronary arteries in thetransplant setting
Authors: Nourani, F Laufer, G Hollensteiner, H Bergmeister, H Buschle, M Khazen, C Ankersmit, J Traxler, H Wolner, E Losert, U Kocher, AA
Citation: F. Nourani et al., Modified technique of delivering solutions to rat coronary arteries in thetransplant setting, TRANSPLAN P, 31(8), 1999, pp. 3255-3256
Risultati: 1-8 |